Quick read
The UFC issued an official statement announcing that flyweight prospect Alibi Idiris has accepted a 12‑month suspension under the UFC Anti‑Doping Policy after testing positive for the diuretic hydrochlorothiazide in an in‑competition sample. The violation stems from a test collected on February 21, 2026, and his suspension is set to run from that date until February 21, 2027. The case highlights the promotion’s ongoing strict enforcement of anti‑doping rules. For Idiris, the layoff pauses his momentum in the flyweight division and delays any potential return to competition.
AgentMMA.com
